Ahmad A. Tarhini, Sandra J. Lee, Diwakar Davar, Craig L. Slingluff, Jane Messina, Gary Irvin Cohen, G. Paul Wright, Andrew Stewart Poklepovic, Yana G. Najjar, Jessica A. Cintolo-Gonzalez, Jose Lutzky, Elizabeth Mary Gaughan, Janice M. Mehnert, Jedd D. Wolchok, John M. Kirkwood. "A phase II randomized study of neoadjuvant pembrolizumab (P) alone or in combination with vidutolimod (V) in high-risk resectable melanoma: ECOG-ACRIN EA6194.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.17_suppl.lba9505